Volume has been increasing. Positive sign in my opinion. Plus the share price is holding up. I think investors are return to biotechs. Biogen in the US got an approval for an Alzheimers drug overnight. An unmet medical need. I'll be following its share price action to see how the markets value the stock https://www.abc.net.au/news/2021-06-08/us-approves-first-alzheimers-drug-in-20-years/100197170
Note the market cap is 59 Billion.....
Returning to Recce, the announcement yesterday from management is very much appreciated. No more need to guess when we get more data. Despite the stall in the share price I think Recce has a very bright future.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)